- Original article
- Open access
- Published:
Hepatopulmonary syndrome in noncirrhotic patients with chronic viral hepatitis
Egyptian Journal of Bronchology volume 8, pages 175–180 (2014)
Abstract
Background
Hepatopulmonary syndrome (HPS) is hypoxemia and functional intrapulmonary right-to-left shunts in patients with liver disease. It is a well-known complication of liver cirrhosis, portal hypertension, and acute liver failure.
Aim
The aim of this study was to determine the extent to which pulmonary functions were affected and the possible existence of HPS in noncirrhotic patients with chronic viral hepatitis.
Patients and methods
Lung function tests were carried out on 60 patients with chronic viral hepatitis (43 with hepatitis C and 17 with hepatitis B). All hypoxemic patients or patients with reduced diffusion capacity were subjected to contrast echocardiography to demonstrate intrapulmonary shunting.
Results
Twelve patients showed pulmonary dysfunction. Only seven of 60 patients (11.67%) showed hypoxemia. Intrapulmonary shunting was observed in three of those 12 patients. Two of these patients fulfilled the diagnostic criteria of HPS.
Conclusion
HPS exists in some patients with chronic viral hepatitis and is thus not restricted to patients with end-stage liver disease. Egypt J Broncho 2014 8:175–180
References
Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122:521–529.
Rodriguez-Roisin R, Agusti AG, Roca J. The hepatopulmonary syndrome, new name, old complexities. Thorax 1992; 47:897–902.
Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994; 105:1528–1537.
Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, et al. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987; 135:1085–1092.
Hedenstierna G, Sdöerman C, Eriksson LS, et al. Ventilation-perfusion inequality in patients with nonalcoholic liver cirrhosis. Eur Respir J 1991; 4:711–717.
Krowka MJ, Tajik AJ, Dickson ER, et al. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97:1165–1170.
Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 1992; 70:516–519.
Abrams GA, Jaffe CC, Hoffer PB, et al. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109:1283–1288.
Stoller JK, Lange PA, Wetveer MK, et al. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med 1995; 163:133–138.
Abrams GA, Nanda NC, Dubovsky EV, et al. Use of macro-aggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998; 114:305–310.
Martínez GP, Barberà JA, Visa J, Rimola A, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001; 34:651–657.
Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary complication of liver disease. Clin Chest Med 1996; 17:35–48.
Krowka MJ, Porayko MK, Plevak DJ, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997; 72:44–53.
Krowka MJ, Cortese DA. Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc 1985; 60:407–418.
Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513–1520.
Brooks SM. Task group on surveillance for respiratory hazards. ATS News 1982; 8:12–16.
Zeuzem S, Franke A, Lee JH, et al. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996; 24:1003–1009.
American Thoracic Society. Standardization of spirometry, 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:1285–1298.
Gardner RM, Clausen JL, Crapo RO, et al. Quality assurance in pulmonary function laboratories. Am Rev Respir Dis 1986; 134:625–627.
Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests. European Community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6:5–40.
American Thoracic Society. ATS Statement. Single breath carbon monoxide diffusion capacity (transfer factor): recommendations for a standard technique, 1995 update. Am J Respir Crit Care Med 1995; 152:2185–2198.
Schlief R. Ultrasound contrast agents. Curr Opinion Radiol 1991; 3:198–207.
Schlief R, Schurmann R, Niendorf HP. Basic properties and results of clinical trials of ultrasound contrast agents based on galactose. Ann Acad Med Singapore 1993; 22:762–767.
American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202–1218.
Bauer A, Schlief R. In: Goldberg BB, editor. Ultrasound contrast agents. Diagnostics of vascular diseases. Principles and technology. Berlin: Springer 1997; 75–82.
Regev A, Yeshurun M, Rodriguez M, et al. Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat 2001; 8:83–86.
Fuhrmann V, Madl C, Mueller C, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006; 131:69–75.
El Makarem MA, Elakad A, Ali A, et al. Hepatopulmonary syndrome: prevalence and predictors in Egyptian cirrhotic patients. Trop Gastroenterol 2011; 32:25–30.
Anand AC, Mukherjee D, Rao KS, et al. Hepatopulmonary syndrome: prevalence and clinical profile. Indian J Gastroenterol 2001; 20:24–27.
RO Crapo. Current concepts: pulmonary-function testing. New Engl J Med 1994; 331:25–30.
O’Connor GT, Anderson KM, Kannel WB. Prevalence and prognosis of dyspnea in the Framingham Study. Chest 1987; 92:90S.
Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med 1991; 90:693–700.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
El-Habashy, M.M., Khamis, A.A., Kamel, M. et al. Hepatopulmonary syndrome in noncirrhotic patients with chronic viral hepatitis. Egypt J Bronchol 8, 175–180 (2014). https://doi.org/10.4103/1687-8426.145728
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/1687-8426.145728